J&J sees AI halving the time to generate drug development leads
Johnson & Johnson is using the new technology to screen the 'potential universe' for promising chemical compounds or biologics, CIO Jim Swanson says
Original Source
Read the full article at Rappler →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.